
Imaxio
Developer of medicinal products and vaccines designed to treat human leptospirosis. The company's preclinical-stage products are based on an antigen re-engineering platform to improve immunogenicity, ...
Valuation
$0
Share Price
N/A
Total Raised
$10.8M
Last Round
N/A